| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 50 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $411.6K | - | |
| CFO | 26.0K | $178.4K | - | |
| Dir | 7.0K | $48.0K | - | |
| Dir | 7.0K | $48.0K | - | |
| Dir | 7.0K | $48.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $53.14 | $2,106,251.88 | -0.2% | |
| Mar 8, 2018 | Cotroneo Pat | VP, Finance And CFO | Sell | 1,894 | $53.12 | $100,617.26 | -0.4% | |
| Feb 23, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $56.66 | $2,245,794.91 | -0.2% | |
| Feb 16, 2018 | Cotroneo Pat | VP, Finance And CFO | Sale+OE | 49,500 | $55.96 | $2,770,078.80 | -4.0% | |
| Feb 15, 2018 | Kurkijarvi Kalevi | Director | Sale+OE | 6,000 | $55.69 | $334,119.00 | -12.7% | |
| Feb 15, 2018 | Rosenkranz Roberto Pedro | Director | Sale+OE | 1,000 | $55.90 | $55,898.00 | -1.7% | |
| Feb 15, 2018 | Routti Jorma | Director | Sale+OE | 12,000 | $55.30 | $663,565.95 | -1.8% | |
| Feb 8, 2018 | Yu K Peony | Chief Medical Officer | Sell | 7,500 | $53.97 | $404,778.00 | -2.5% | |
| Jan 30, 2018 | Neff Thomas B | Chief Executive Officer | Sell | 38,636 | $61.40 | $2,372,094.56 | -0.2% | |
| Jan 29, 2018 | Yu K Peony | Chief Medical Officer | Sell | 10,000 | $62.00 | $620,000.00 | -6.2% |